These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10535175)

  • 1. [Pharmacologic and toxicologic results in genetic polymorphisms (review)].
    Kohút A; Kalina I
    Cesk Fysiol; 1998 Dec; 47(4):172-84. PubMed ID: 10535175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic polymorphism of enzymes metabolizing xenobiotics as a factor in susceptibility to tumor development].
    Salagovic J; Kalina I; Dudas M
    Bratisl Lek Listy; 2000; 101(9):512-21. PubMed ID: 11187056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to lung cancer--relevance to smoking].
    Uematsu F
    Nihon Rinsho; 1996 Feb; 54(2):513-7. PubMed ID: 8838107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility.
    Reszka E; Wasowicz W; Gromadzinska J
    Br J Nutr; 2006 Oct; 96(4):609-19. PubMed ID: 17010218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-environment interactions in esophageal cancer.
    Matejcic M; Iqbal Parker M
    Crit Rev Clin Lab Sci; 2015; 52(5):211-31. PubMed ID: 26220475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients.
    Dolzan V; Rudolf Z; Breskvar K
    Pflugers Arch; 2000; 439(3 Suppl):R29-30. PubMed ID: 10653131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of genetically determined acetylation of drugs and xenobiotics in pathogenesis of neoplasms].
    Niewiński P; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 1997 Jan; 2(9):231-5. PubMed ID: 10907039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes.
    Ginsberg G; Smolenski S; Neafsey P; Hattis D; Walker K; Guyton KZ; Johns DO; Sonawane B
    J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):307-33. PubMed ID: 20183525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in xenobiotic metabolism.
    Smith CA; Smith G; Wolf CR
    Eur J Cancer; 1994; 30A(13):1921-35. PubMed ID: 7734203
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxicogenetics and toxicogenomics. Relevance and application in occupational health].
    Schulz T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1004-10. PubMed ID: 17013775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.
    Neafsey P; Ginsberg G; Hattis D; Sonawane B
    J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):334-61. PubMed ID: 20183526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactions and enzymes in the metabolism of drugs and other xenobiotics.
    Testa B; Pedretti A; Vistoli G
    Drug Discov Today; 2012 Jun; 17(11-12):549-60. PubMed ID: 22305937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM
    Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M; Pelkonen O
    IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modulating effects of endogenous substances on drug metabolising enzymes and implications for inter-individual variability and quantitative prediction.
    Azam YJ; Machavaram KK; Rostami-Hodjegan A
    Curr Drug Metab; 2014; 15(6):599-619. PubMed ID: 25255874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for differences in susceptibility to toxicants: introduction.
    Boobis AR
    Toxicol Lett; 1992 Dec; 64-65 Spec No():109-13. PubMed ID: 1471164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemistry of drug metabolism--an introduction: part 6. Inter-individual factors affecting drug metabolism.
    Krämer SD; Testa B
    Chem Biodivers; 2008 Dec; 5(12):2465-578. PubMed ID: 19089818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.